IFITM1 and breast carcinoma: To our knowledge, this is the first study to demonstrate a link between dysregulation of the interferon signaling pathway and AI resistance and it suggests that targeting IFITM1 might be an effective strategy to block cell proliferation and enhance E2-induced cell death in AI-resistant breast cancer cells.